Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:42 pm Purchase | 13G | Cytosorbents Corp CTSO | AVENIR CORP | 3,051,402 6.870% | 604,313 (+24.70%) | View |
2023-02-14 1:08 pm Purchase | 13G | Cytosorbents Corp CTSO | AVENIR CORP | 2,447,089 5.610% | 259,307 (+11.85%) | View |
2022-08-11 08:39 am Purchase | 13G | Cytosorbents Corp CTSO | AVENIR CORP | 2,187,782 5.020% | 30,949 (+1.43%) | View |
2022-06-27 5:34 pm Sale | 13G | Cytosorbents Corp CTSO | AVENIR CORP | 2,156,833 4.950% | -20,313 (-0.93%) | View |
2022-04-22 5:34 pm Purchase | 13G | Cytosorbents Corp CTSO | AVENIR CORP | 2,177,146 5.000% | 89,075 (+4.27%) | View |
2022-01-07 5:10 pm Sale | 13G | Cytosorbents Corp CTSO | AVENIR CORP | 2,088,071 4.800% | -156,264 (-6.96%) | View |
2021-12-13 5:01 pm Purchase | 13G | Cytosorbents Corp CTSO | AVENIR CORP | 2,244,335 5.160% | 2,244,335 (New Position) | View |
2021-02-05 10:25 am Sale | 13G | OptimizeRx Corp OPRX | AVENIR CORP | 704,756 4.660% | -12,718 (-1.77%) | View |
2020-05-05 4:39 pm Sale | 13G | DENNYS CORP DENN | AVENIR CORP | 2,726,560 4.900% | -261,312 (-8.75%) | View |
2020-02-27 2:14 pm Purchase | 13G | OptimizeRx Corp OPRX | AVENIR CORP | 717,474 5.060% | 717,474 (New Position) | View |
2020-02-27 1:57 pm Sale | 13G | DENNYS CORP DENN | AVENIR CORP | 2,987,872 5.060% | -1,091,760 (-26.76%) | View |